Literature DB >> 25932993

Negative pressure wound therapy for seroma prevention and surgical incision treatment in spinal fracture care.

Matthias Nordmeyer1, Johannes Pauser1,2, Roland Biber1, Jonathan Jantsch3, Siegfried Lehrl4, Carsten Kopschina1, Christian Rapke1, Hermann J Bail1, Raimund Forst5, Matthias H Brem1,6.   

Abstract

To evaluate the clinical use and economic aspects of negative pressure wound therapy (NPWT) after dorsal stabilisation of spinal fractures. This study is a prospective randomised evaluation of NPWT in patients with large surgical wounds after surgical stabilisation of spinal fractures by internal fixation. Patients were randomised to either standard wound dressing treatment (group A) or NPWT (group B). The wound area was examined by ultrasound to measure seroma volumes in both groups on the 5th and 10th day after surgery. Furthermore, data on economic aspects such as nursing time for wound care and material used for wound dressing were evaluated. A total of 20 patients (10 in each group) were enrolled. Throughout the whole study, mean seroma volume was significantly higher in group A than that in group B (day 5: 1·9 ml versus 0 ml; P = 0·0007; day 10: 1·6 ml versus 0·5 ml; P <0·024). Furthermore, patients of group A required more wound care time (group A: 31 ± 10 minutes; group B 13·8 ± 6 minutes; P = 0·0005) and more number of compresses (total number; group A 35 ± 15; group B 11 ± 3; P = 0·0376). NPWT reduced the development of postoperative seroma, reduced nursing time and reduced material required for wound care.
© 2015 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  NPWT; Spinal fracture; Wound complication; Wound healing

Mesh:

Year:  2015        PMID: 25932993      PMCID: PMC7949832          DOI: 10.1111/iwj.12436

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


Introduction

In recent years, negative pressure wound therapy (NPWT) became a widely used therapy for many different indications in the treatment of wounds 1, 2, 3, 4. Recently, NPWT has also been used in the treatment of closed surgical wounds. The incisional NPWT (iNPWT) has shown beneficial effects when administered after severe trauma 5, 6, 7, 8. The indications and the evidence for the efficacy of iNPWT have increased recently 9, 10, 11. However, only a few prospective randomised studies have been published on those indications mostly dealing with hip arthroplasty 11, 12. The mode of action of iNPWT is still not completely understood. This is thought to be mediated by increased oxygen delivery to the tissue as result of enhanced tissue perfusion and promotion of angiogenesis 5, 9, 13. The purpose of this study was to evaluate the different aspects of wound healing in spinal fractures treated by internal fixation. We compared a standard wound dressing group with an iNPWT group in the context of postoperative seroma formation in the wound area, the total time of secretion, the total time needed for the wound care (dressing changes) and the material needed for dressing changes.

Materials and methods

A total of 20 patients with spinal fractures were scheduled for internal fixation. They were randomised into two groups. Group A (10 patients) received the standard wound dressing of our department, consisting of a dry wound coverage (compresses attached to the skin). Group B (10 patients) was treated with iNPWT over the sutured wound area. The surgical intervention was identical in both the groups. An open reduction technique with internal fixation system was performed for all the patients, which was obtained from the same manufacturer (Synthes, West Chester, PA). All patients received two Redon® drains, one on each side of the spinal column subcutaneously. Postoperative physiotherapy and mobilisation were also identical for both the groups. The iNPWT group (group B) was treated with a PICO™ system (Smith & Nephew plc, London, UK). The PICO™ system was left on the wound for 5 days including the day of surgery. In addition to daily clinical examination, all wounds/seroma were analysed by ultrasonography on the 5th and 10th day after surgery. Before surgery, plasmatic coagulation was assessed in all patients using the Quick prothrombin time test. Postoperatively, the immediate amount of wound secretion in the Redon drain canisters was quantified. In addition, the length of the incision was measured. The duration of secretion from the wounds was monitored and the total number of dressing changes and the time required to perform the dressing changes were also assessed. The material used for dressing changes was also quantified (compresses and gloves). Statistical significance was calculated with the Prism v6.0 GraphPad Software, Inc. (La Jolla, CA). For Gaussian distributed data, the Student's t‐test was used. For non‐Gaussian distributed data, the Mann–Whitney test was used. Informed consent was obtained from each patient. The study was approved by the local ethics committee (Re‐No.139_12 B) and conforms to the principles of the Declaration of Helsinki.

Results

In this study, 10 patients (mean age 57·80 ± 15·24 years) were randomised to group A and 10 patients (mean 52·30 ± 16·32 years) to group B. Both groups displayed normal coagulation times according to the Quick prothrombin time test (group A: 94·20 ± 9·52%; group B: 96·00 ± 7·80%; P = 0·73). There was no significant difference in the postoperative wound size between both groups (group A: 17·25 ± 5·70 cm; group B: 14·60 ± 4·38 cm; P = 0·26). Furthermore, both groups displayed almost equal volumes of wound secretion in the Redon® drain canisters after 2 days (group A: 621·5 ± 286·5 ml; group B: 454·0 ± 229·6 ml; P = 0·16). The seroma volume underneath the surgical wound was significantly lower at day 5 and day 10 in the iNPWT group (day 5: group A: 1·9 ± 2·7 ml versus group B: 0 ± 0 ml (P = 0·0007); day 10: group A: 1·6 ± 2·6 ml versus group B: 0·5 ± 1·0 ml; P = 0·024). The patients treated with iNPWT required fewer dressing changes: 48 dressing changes in group B patients, equating to 4·8 per patient and 79 dressing changes in group A patients equating to 7·9 per patient (Figure 1). Group B patients also had lesser number of days of wound secretion (Figure 2) and required lesser time for wound care (Figure 3) and lesser material for dressing changes (Figures 4 and 5).
Figure 1

Distribution of number of dressing changes (P < 0·0001).

Figure 2

Distribution of number of days of wound secretion.

Figure 3

Distribution of wound care time.

Figure 4

Distribution of number of used gloves for dressing changes.

Figure 5

Distribution of number of used compresses for dressing changes.

Distribution of number of dressing changes (P < 0·0001). Distribution of number of days of wound secretion. Distribution of wound care time. Distribution of number of used gloves for dressing changes. Distribution of number of used compresses for dressing changes.

Discussion

Since the development of NPWT, the indications for the use of NPWT have been mainly acute and chronic wounds 1, 2, 3, 14, 15, 16, 17, 18; however, the indications have increased over time 2, 19. NPWT exerts a positive effect on wound healing resulting in a reduction in wound healing complications. Furthermore, NPWT treatment excels because of its ease of application and a low risk of side effects 20, 21. Recent studies using NPWT showed a reduction of seromas in wounds after hip surgery. The beneficial effect of NPWT was found after elective total hip arthoplasty and after arthroplasty of femoral neck fractures 11, 12. A recently published review confirmed the reduction of wound complications in high‐risk wounds 9. In our study, we evaluated for the first time the possible effects of iNPWT in spinal fractures treated with open reduction and internal fixation. Besides the anatomical area of application, it is the first prospective randomised study in orthopaedics using the PICO™ system (Figure 6) (Smith & Nephew plc).
Figure 6

Application of a PICO system to the wound.

Application of a PICO system to the wound. This study provides compelling evidence that iNPWT may be useful to treat large surgical incision wounds after surgical treatment of spinal fractures. To the best of our knowledge, significant reduction of wound complications in fractures of the spine treated with open reduction and internal fixation by using iNPWT has not been previously reported. In addition, iNPWT treatment reduced the time and dressing material needed for postoperative wound care. The present study used ultrasound as a standardised imaging modality to detect seromas in the wound area. The high sensitivity of this imaging modality allowed for the detection of seroma volumes directly underneath the surgical incision. This method was previously described for the evaluation of iNPWT after surgical interventions of the hip and femoral neck fracture 11, 12. In line with these studies, we found a significant reduction of wound draining days in the iNPWT group compared with that in the control group. In addition to reduced wound secretion, Stannard et al. showed that iNPTW treatment reduced haematoma size in patients suffering from high‐energy trauma injuries 5, 22. Given the fact that haemotomas might favour as nutrient‐rich environments for bacterial replication and that persisting wound drainage might facilitate the entrance of bacteria into the wounds, the reduction of wound secretion and the haematoma size might reduce the risk of a wound infection. Haematomas are thought to serve as rich nutrient sources for infection 23. In our opinion, a prolonged secretion is an important risk factor of early postoperative infections as well. However, to the best of our knowledge, we are not aware of a study that has addressed this issue. Hence, further investigations into these mechanisms are warranted. Furthermore, it is not fully understood how iNPWT leads to a reduced seroma and haematoma formation in the wounded tissue. Horch et al. suggested that NPWT results in a significantly increased tissue perfusion and oxygenation 13. In addition to altering tissue perfusion, treatment with iNPWT might reduce wound edge tension and thereby promote healing 24. Our results in this study are consistent with the findings of other studies regarding the reduction of wound healing complications after the treatment with iNPWT. We and others have demonstrated that wound treatment with iNPWT after elective total hip arthroplasty for the treatment of osteoarthritis of the hip and the treatment with iNPWT after surgical treatment of femoral neck fractures reduced the wound healing complications 11, 12. In addition, patients who suffered from severe soft tissue damage after trauma displayed a faster recovery when the iNPWT device was placed on the wounded tissue at early time points 13, 25. In our study, we attached the iNPWT device immediately after surgical wound closure to the skin over the wound. In a previous study, we observed that the time dedicated to the wound care and the consumption of wound care material were significantly shorter than those in the control group. In agreement with our previous study 11, we found that iNPWT treatment reduced the time needed for wound care and the consumption of wound care material. The 48 dressing changes in the iNPWT group also included the removal of the redon drains and the removal of the device. To avoid a bias, these dressing changes were also documented; the number would have been even smaller if this study‐related dressing changes were not taken into account. Limitations of the present study are the relatively small number of enrolled patients and the use of an iNPWT device from a single manufacturer. The difference between the different manufacturers seems to be relatively small and the principles of NPWT seem to be transferable between the different manufacturers. However, this has to be confirmed by comparative studies.

Conclusion

In summary, our results support the use of iNPWT after spinal surgery. Apart from its economic benefits, iNPWT promotes wound healing and might prevent wound infections, which are the dreaded complications of spine surgery.
  24 in total

1.  The use of vacuum-assisted closure therapy for the treatment of lower-extremity wounds with exposed bone.

Authors:  A J DeFranzo; L C Argenta; M W Marks; J A Molnar; L R David; L X Webb; W G Ward; R G Teasdall
Journal:  Plast Reconstr Surg       Date:  2001-10       Impact factor: 4.730

2.  [Indications and safety aspects of vacuum-assisted wound closure].

Authors:  R E Horch; H Gerngross; W Lang; P Mauckner; D Nord; R U Peter; P M Vogt; W Wetzel-Roth; C Willy
Journal:  MMW Fortschr Med       Date:  2005-04-07

3.  The accelerating effect of negative pressure wound therapy with Prevena™ on the healing of a closed wound with persistent serous secretion.

Authors:  Burak Altintas; Roland Biber; Matthias H Brem
Journal:  Int Wound J       Date:  2014-01-07       Impact factor: 3.315

4.  [Experimental principles of the V.A.C.-therapy -- pressure values in superficial soft tissue and the applied foam].

Authors:  C Willy; H von Thun-Hohenstein; F von Lübken; M Weymouth; T Kossmann; M Engelhardt
Journal:  Zentralbl Chir       Date:  2006-04       Impact factor: 0.942

Review 5.  Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus.

Authors:  E Krug; L Berg; C Lee; D Hudson; H Birke-Sorensen; M Depoorter; R Dunn; S Jeffery; F Duteille; A Bruhin; C Caravaggi; M Chariker; C Dowsett; F Ferreira; J M Francos Martínez; G Grudzien; S Ichioka; R Ingemansson; M Malmsjo; P Rome; S Vig; N Runkel; R Martin; J Smith
Journal:  Injury       Date:  2011-02       Impact factor: 2.586

6.  First experiences with negative pressure wound therapy and instillation in the treatment of infected orthopaedic implants: a clinical observational study.

Authors:  Burkhard Lehner; Wim Fleischmann; Rolf Becker; Gerrolt N Jukema
Journal:  Int Orthop       Date:  2011-05-17       Impact factor: 3.075

Review 7.  Use of negative pressure therapy on closed surgical incisions: a case series.

Authors:  James P Stannard; Broadus Zane Atkins; David O'Malley; Hardayal Singh; Brent Bernstein; Michael Fahey; Derek Masden; Christopher E Attinger
Journal:  Ostomy Wound Manage       Date:  2009-08-01       Impact factor: 2.629

8.  Negative pressure wound therapy after severe open fractures: a prospective randomized study.

Authors:  James P Stannard; David A Volgas; Rena Stewart; Gerald McGwin; Jorge E Alonso
Journal:  J Orthop Trauma       Date:  2009-09       Impact factor: 2.512

9.  [The vacuum-assisted closure (V.A.C.) and instillation dressing: limb salvage after 3 degrees open fracture with massive bone and soft tissue defect and superinfection].

Authors:  M H Brem; M Blanke; A Olk; J Schmidt; O Mueller; F F Hennig; J Gusinde
Journal:  Unfallchirurg       Date:  2008-02       Impact factor: 1.000

10.  Negative pressure wound therapy for managementof the surgical incision in orthopaedic surgery: A review of evidence and mechanisms for an emerging indication.

Authors:  S Karlakki; M Brem; S Giannini; V Khanduja; J Stannard; R Martin
Journal:  Bone Joint Res       Date:  2013-12-18       Impact factor: 5.853

View more
  18 in total

1.  Endoluminal vacuum therapy for gastrojejunal anastomotic leaks after Roux-en-Y gastric bypass: a pilot study in a swine model.

Authors:  Rachel B Scott; Lane A Ritter; Amber L Shada; Sanford H Feldman; Daniel E Kleiner
Journal:  Surg Endosc       Date:  2016-02-29       Impact factor: 4.584

2.  Negative-pressure wound therapy compared with standard dressings following surgical treatment of major trauma to the lower limb: the WHiST RCT.

Authors:  Matthew L Costa; Juul Achten; Ruth Knight; May Ee Png; Julie Bruce; Susan Dutton; Jason Madan; Karan Vadher; Melina Dritsaki; James Masters; Louise Spoors; Marta Campolier; Nick Parsons; Miguel Fernandez; Suzanne Jones; Richard Grant; Jagdeep Nanchahal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

Review 3.  Can prophylactic negative pressure wound therapy improve clinical outcomes in spinal fusion surgery? A meta-analysis.

Authors:  Zhi Chen; Jun Sun; Zhipeng Yao; Chenyang Song; Wenge Liu
Journal:  Eur Spine J       Date:  2022-03-19       Impact factor: 2.721

Review 4.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; Chunhu Shi; En Lin Goh; Elizabeth Ma Murphy; Adam Reid; Laura Chiverton; Monica Stankiewicz; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2022-04-26

5.  The impact of surgical site occurrences and the role of closed incision negative pressure therapy.

Authors:  Christian Willy; Michael Engelhardt; Marcus Stichling; Onnen Grauhan
Journal:  Int Wound J       Date:  2016-09       Impact factor: 3.315

6.  Negative Pressure Wound Therapy (NPWT) in Groin Wounds After Lymphadenectomy in Vulvar Cancer Patients.

Authors:  Katrin Christine Asciutto; Stefan Acosta; Christer Borgfeldt
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

7.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Joan Webster; Zhenmi Liu; Gill Norman; Jo C Dumville; Laura Chiverton; Paul Scuffham; Monica Stankiewicz; Wendy P Chaboyer
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

8.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; En Lin Goh; Jo C Dumville; Chunhu Shi; Zhenmi Liu; Laura Chiverton; Monica Stankiewicz; Adam Reid
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

9.  Biomechanical Modeling of the Forces Applied to Closed Incisions During Single-Use Negative Pressure Wound Therapy.

Authors:  John Loveluck; Tom Copeland; Jason Hill; Allan Hunt; Robin Martin
Journal:  Eplasty       Date:  2016-07-13

10.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; En Lin Goh; Jo C Dumville; Chunhu Shi; Zhenmi Liu; Laura Chiverton; Monica Stankiewicz; Adam Reid
Journal:  Cochrane Database Syst Rev       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.